Three-year follow-up of accelerated transepithelial corneal cross-linking for progressive paediatric keratoconus.
CONCLUSIONS: ATE-CXL is a safe and effective treatment in paediatric progressive keratoconus patients, leading to stable keratometry and corneal thickness throughout the 36-month follow-up.
PMID: 32051139 [PubMed - as supplied by publisher]
Source: The British Journal of Ophthalmology - Category: Opthalmology Authors: Tian M, Jian W, Zhang X, Sun L, Zhou X Tags: Br J Ophthalmol Source Type: research
More News: Boys | Children | Eyes | Girls | Keratoconus | Opthalmology | Pediatrics | Study | UK Health